ATE208611T1 - Flubendazole-kautabletten für haustiere - Google Patents

Flubendazole-kautabletten für haustiere

Info

Publication number
ATE208611T1
ATE208611T1 AT95919448T AT95919448T ATE208611T1 AT E208611 T1 ATE208611 T1 AT E208611T1 AT 95919448 T AT95919448 T AT 95919448T AT 95919448 T AT95919448 T AT 95919448T AT E208611 T1 ATE208611 T1 AT E208611T1
Authority
AT
Austria
Prior art keywords
flubendazole
pct
pets
chewable tablets
sec
Prior art date
Application number
AT95919448T
Other languages
English (en)
Inventor
Eugene Marie Jozef Jans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE208611T1 publication Critical patent/ATE208611T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
    • A23K10/37—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material
    • A23K10/38—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from waste material from distillers' or brewers' waste
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
    • Y02P60/87—Re-use of by-products of food processing for fodder production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT95919448T 1994-05-20 1995-05-12 Flubendazole-kautabletten für haustiere ATE208611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94201434 1994-05-20
PCT/EP1995/001801 WO1995031963A1 (en) 1994-05-20 1995-05-12 Chewable flubendazole tablets for companion animals

Publications (1)

Publication Number Publication Date
ATE208611T1 true ATE208611T1 (de) 2001-11-15

Family

ID=8216895

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95919448T ATE208611T1 (de) 1994-05-20 1995-05-12 Flubendazole-kautabletten für haustiere

Country Status (22)

Country Link
US (1) US5824336A (de)
EP (1) EP0760648B1 (de)
JP (1) JPH10501211A (de)
AT (1) ATE208611T1 (de)
AU (1) AU690994B2 (de)
BR (1) BR9507637A (de)
CA (1) CA2190357C (de)
CY (1) CY2255B1 (de)
CZ (1) CZ290406B6 (de)
DE (1) DE69523912T2 (de)
DK (1) DK0760648T3 (de)
ES (1) ES2167436T3 (de)
FI (1) FI118324B (de)
HU (1) HU225958B1 (de)
IL (1) IL113782A (de)
NO (1) NO313402B1 (de)
NZ (1) NZ285766A (de)
PL (1) PL185332B1 (de)
PT (1) PT760648E (de)
SI (1) SI0760648T1 (de)
WO (1) WO1995031963A1 (de)
ZA (1) ZA954128B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2317560A (en) * 1996-09-20 1998-04-01 Edmund John Hilary Campion Anti-parasite medication for pets
WO2001021178A2 (en) * 1999-09-22 2001-03-29 Akzo Nobel, N.V. Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US20050271708A1 (en) * 2002-03-05 2005-12-08 Thombre Avinash G Palatable controlled-release formulation for companion animals
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
EP1759692A3 (de) * 2003-03-10 2007-09-12 Novartis AG Geschmacksüberdeckte feste arzneiformen für Tiere
GB2399752A (en) * 2003-03-26 2004-09-29 Micap Plc Pharmaceutical composition comprising a fungal cell or cell fragment as adjuvant
AR045142A1 (es) * 2003-07-30 2005-10-19 Novartis Ag Composicion veterinaria masticable ductil de buen sabor
MXPA06002257A (es) * 2003-08-26 2006-05-17 Shire Holdings Ag Farmaceutica que comprende compuestos de lantano.
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (de) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Verwendung von PDE III Ihibitoren zur Reduktion der Herzgrösse in an Herzversagen leidenden Säugern
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US7348027B2 (en) * 2005-04-08 2008-03-25 Bayer Healthcare Llc Taste masked veterinary formulation
EP1920785A1 (de) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Pimobendan-Cyclodextrin Komplex enthaltendes flüssiges Präparat
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
CN104168900A (zh) 2012-02-06 2014-11-26 梅里亚有限公司 包含全身性地起作用的活性剂的杀寄生虫口服兽用组合物、方法及其用途
EP3167876B1 (de) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmazeutische tablettenformulierung für den veterinärmedizinischen sektor, verfahren zur herstellung und verwendung davon
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
CN111803465B (zh) 2013-03-15 2023-05-09 阿根塔创新有限公司 可咀嚼配制物
DK3021832T3 (da) 2013-07-19 2021-05-25 Boehringer Ingelheim Vetmedica Gmbh Konserverede etherificerede cyclodextrinderivater indeholdende flydende vandig farmaceutisk sammensætning
JP6117079B2 (ja) * 2013-10-01 2017-04-19 富士フイルム株式会社 チュアブル錠用組成物及びチュアブル錠
US20150164047A1 (en) * 2013-11-07 2015-06-18 Urban Pet Haus, LLC Edible cat toy
ES2593210T3 (es) 2013-12-04 2016-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE944581C (de) * 1953-10-15 1956-06-21 Waldhof Zellstoff Fab Verfahren zur Herstellung einer Pilengrundmasse
AU5957480A (en) * 1979-07-26 1981-01-29 American Cyanamid Company Diethyl carbamazine resinate
US4578268A (en) * 1979-07-26 1986-03-25 American Cyanamid Company Diethylcarbamazine resinate and styrylpyridinium resinate-diethylcarbamazine resinate edible anthelmintic tablets for companion animals
JPS5821615A (ja) * 1981-07-29 1983-02-08 Fujisawa Pharmaceut Co Ltd 草食獣の肝蛭症の予防治療剤
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
FR2623976B1 (fr) * 1987-12-08 1994-02-25 So Ge Val Comprime pour animal domestique

Also Published As

Publication number Publication date
HK1010695A1 (en) 1999-06-25
HU225958B1 (en) 2008-01-28
JPH10501211A (ja) 1998-02-03
ZA954128B (en) 1996-11-19
FI964623L (fi) 1996-11-19
CZ333596A3 (en) 1997-02-12
EP0760648A1 (de) 1997-03-12
EP0760648B1 (de) 2001-11-14
DE69523912T2 (de) 2002-06-27
AU2527295A (en) 1995-12-18
CZ290406B6 (cs) 2002-07-17
CA2190357C (en) 2007-04-17
IL113782A (en) 1999-08-17
DK0760648T3 (da) 2002-02-25
CA2190357A1 (en) 1995-11-30
PT760648E (pt) 2002-04-29
NO964912L (no) 1996-11-19
NO964912D0 (no) 1996-11-19
DE69523912D1 (de) 2001-12-20
BR9507637A (pt) 1997-10-07
PL317227A1 (en) 1997-03-17
FI964623A0 (fi) 1996-11-19
FI118324B (fi) 2007-10-15
CY2255B1 (en) 2003-07-04
ES2167436T3 (es) 2002-05-16
HU9603215D0 (en) 1997-01-28
IL113782A0 (en) 1995-08-31
US5824336A (en) 1998-10-20
PL185332B1 (pl) 2003-04-30
NZ285766A (en) 1997-09-22
WO1995031963A1 (en) 1995-11-30
NO313402B1 (no) 2002-09-30
HUT74988A (en) 1997-03-28
SI0760648T1 (en) 2002-04-30
AU690994B2 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
DE69523912D1 (de) Flubendazole-kautabletten für haustiere
ATE179976T1 (de) Neue 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazol-derivate
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
AU7285487A (en) Anthelmintic quaternaryalkyl acylhydrazones, method of use and compositions
BR0215277A (pt) Dicetopiperazinas substituìdas como antagonistas da oxitocina
ES8801544A1 (es) Procedimiento para preparar piridinil acilhidrazonas
DE69823493D1 (de) Tetrahydropyridoverbindungen
BR0311970A (pt) Novos compostos, seu uso e preparação
BR9612196A (pt) Tiazolinas substituidas
MX9605709A (es) Tabletas masticables de flubendazol para animales de compañia.
GB0003234D0 (en) Method of treatment
MX2007003307A (es) 4-bencil-1,3-dihidro-imidazol-2-tionas substituidas y no substituidas que actuan como agonistas adrenergicos alfa2 especificos o selectivos y metodos de uso de las mismas.
PT1308446E (pt) 5-(alquilideno-cicloalquil) - e 5-(alquilideno- heterociclil) pirazoles
ES2140683T3 (es) Procedimiento para preparar compuestos de benzopirano.
BR9808210A (pt) Befeniloxazolinas dissubstituìdas
DK0877598T3 (da) Anthelmintisk pasta
BR0015482A (pt) Antagonistas de difenil leucotrieno de heterociclo substituìdo
DE60120398D1 (de) Imidazopyridin-8-one
BR0204429A (pt) Heterociclo-alquilsulfonil-pirazóis
ATE148342T1 (de) Verwendung von dioxapyrrolomycin als antiparasitisches mittel und dafür verwendbare zusammensetzung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification